Classifying and communicating risks in prediabetes according to fastingglucose and/or glycated hemoglobin: PREDAPS cohort study

dc.contributor.authorRegidor, Enrique
dc.contributor.authorCea Soriano, Lucía
dc.contributor.authorRuiz García, Antonio
dc.contributor.authorGoday, Albert
dc.contributor.authorCarabantes, David
dc.contributor.authorDíez Espino, Javier
dc.contributor.authorArtola, Sara
dc.contributor.authorFranch Nadal, Josep
dc.contributor.authorPREDAPS Study Group
dc.date.accessioned2023-08-04T11:05:04Z
dc.date.available2023-08-04T11:05:04Z
dc.date.issued2021
dc.description.abstractObjective: Information about prognostic outcomes can be of great help for people with prediabetes and for physicians in the face of scientific controversy about the cutoff point for definingprediabetes. We aimed to estimate different prognostic outcomes in people with prediabetes. Design: Prospective cohort of subjects with prediabetes according to American Diabetes Association guidelines. Main Outcome measures: The probabilities of diabetes onset versus non-onset, the oddsagainst diabetes onset, and the probability of reverting to normoglycemia according to different prediabetes categories were calculated. Results: The odds against diabetes onset ranged from 29:1 in individuals with isolated FPG of100–109mg/dL to 1:1 in individuals with FPG 110–125mg/dL plus HbA1c 6.0–6.4%. The probability of reversion to normoglycemia was 31.2% (95% CI 24.0–39.6) in those with isolated FPG100–109mg/dL and 6.2% (95% CI 1.4–10.0) in those with FPG 110–125mg/dL plus HbA1c6.0–6.4%. Of every 100 participants in the first group, 97 did not develop diabetes and 31reverted to normoglycemia, while in the second group those figures were 52 and 6. Conclusions: Using odds of probabilities and absolute numbers might be useful for people with prediabetes and physicians to share decisions on potential interventions.spa
dc.description.filiationUEMspa
dc.description.impact3.147 Q2 JCR 2021spa
dc.description.impact0.805 Q2 SJR 2021Spa
dc.description.impactNo data IDR 2021Spa
dc.description.sponsorshipSanofispa
dc.description.sponsorshipNovartisspa
dc.identifier.citationRegidor, E., Cea-Soriano, L., Ruiz, A., Goday, A., Carabantes, D., Díez-Espino, J., Artola, S., Franch-Nadal, J., & PREDAPS Study Group (2021). Classifying and communicating risks in prediabetes according to fasting glucose and/or glycated hemoglobin: PREDAPS cohort study. Scandinavian Journal of Primary Health Care, 39(3), 355-363. https://doi.org/10.1080/02813432.2021.1958497spa
dc.identifier.doi10.1080/02813432.2021.1958497
dc.identifier.issn0281-3432
dc.identifier.issn1502-7724
dc.identifier.urihttp://hdl.handle.net/11268/12254
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1080/02813432.2021.1958497spa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen accessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherEstado Prediabéticospa
dc.subject.otherEnfermedades Metabólicasspa
dc.subject.unescoEnfermedad nutricionalspa
dc.titleClassifying and communicating risks in prediabetes according to fastingglucose and/or glycated hemoglobin: PREDAPS cohort studyspa
dc.typejournal articlespa
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Regidor_2021.pdf
Size:
1.55 MB
Format:
Adobe Portable Document Format
Description:
Versión del editor